News

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...
For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can ...
New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
Can a diet pill treat cancer? There is fresh evidence that indicates type 2 diabetes and obesity medications GLP-1 receptor ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...
Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...